AMERISOURCEBERGEN CORP ABC Cash Flow

Amerisourcebergen corp (ABC)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08
OPERATING ACTIVITIES
Net income attributable to AmerisourceBergen Corporation shareholders
-	-	-	-	-	-	-	-	-	-	-	0	0	1,345	-	1,643	1,508	391	-138	-433	-660	32	274	259	440	306	433	546	559	725	718	702	705	708	706	700	679	645	636	625	581	543	503	0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
1,591	648	854	915	891	1,145	1,615	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7	-7	97	-61	-59	-87	-200	-50	-42	0	0	0	-	-	-	-	-	-	-	-	-8	0	0	0
Income (loss) from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	281	266	343	367	493	633	759	776	761	0	0	0	-	-	-	-	-	-	-	-	511	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, including amounts charged to cost of goods sold
292	306	321	331	348	335	318	303	277	268	262	253	246	240	232	227	216	203	193	185	178	172	165	153	147	142	138	134	129	121	113	95	92	90	89	84	77	72	67	80	78	76	74	0	0	0
Amortization, including amounts charged to interest expense
142	164	176	180	196	198	191	191	179	169	169	170	169	168	159	139	119	90	62	47	33	29	31	31	31	31	32	32	31	28	26	20	18	18	17	17	17	17	17	21	20	20	19	0	0	0
Provision for doubtful accounts
36	19	25	26	29	28	16	5	2	5	8	10	10	9	13	22	16	13	8	6	12	23	26	28	28	22	20	8	13	16	23	32	34	39	37	38	42	37	41	38	32	33	31	0	0	0
(Benefit) provision for deferred income taxes
-17	11	28	-3	27	91	-795	-654	-638	-570	319	315	321	529	-130	-184	-266	-572	20	49	43	17	38	-14	-21	12	25	27	67	70	61	118	174	181	194	144	92	86	83	99	99	92	84	0	0	0
Warrants expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	140	-316	-247	1,008	912	1,264	1,424	677	422	317	208	206	90	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
66	58	58	57	55	61	62	64	65	65	62	60	66	71	64	71	67	63	60	57	54	51	43	41	39	38	36	34	32	29	25	24	27	26	27	27	25	29	29	30	29	26	27	0	0	0
Inventory, LIFO Reserve, Period Charge
84	-6	-22	3	-2	64	67	-91	-99	-186	-157	-156	-51	126	200	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of PharMEDium assets
361	708	570	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on early retirement of debt
-	-	-	-	-	-	-23	-23	-23	-23	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-47	-47	-47	-48	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
22	-5	23	15	38	30	19	7	-22	-21	-7	1	14	12	7	8	8	17	11	10	3	5	6	-3	-2	-0	-3	9	13	10	9	3	-3	-7	-5	-14	-13	-12	-9	7	17	18	13	0	0	0
Changes in operating assets and liabilities, excluding the effects of acquisitions:
Accounts receivable
2,413	890	1,241	222	948	1,408	657	966	1,450	649	1,277	1,626	858	1,373	912	1,315	1,139	788	1,478	1,271	1,253	1,545	938	2,012	2,390	2,042	2,312	886	443	587	-71	-191	-66	-481	23	27	-48	-158	-62	753	727	909	457	0	0	0
Inventories
-99	-99	167	233	-380	443	4	-346	680	178	431	987	616	632	1,107	1,628	1,814	470	1,379	1,002	429	1,774	1,304	2,090	2,798	2,817	1,486	722	613	94	116	76	-63	773	228	313	233	404	241	859	1,127	1,142	765	0	0	0
Prepaid expenses and other assets
-12	-19	6	-16	-14	75	57	69	82	31	-33	57	37	21	46	-14	-34	16	37	24	60	11	-21	74	143	140	169	64	6	-5	-49	-24	-16	-57	26	-27	-48	-8	-10	50	13	15	15	0	0	0
Accounts payable
2,606	849	1,561	1,359	1,825	2,416	859	1,060	1,506	1,166	1,473	2,111	1,291	1,636	3,011	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
-	7	-	-	-	-127	209	274	260	280	27	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses and other liabilities
102	18	238	-603	-752	-507	-551	495	750	581	642	119	-101	42	-43	-3,323	-2,432	-3,460	152	2,110	1,009	3,062	55	3,913	4,664	4,129	3,818	2,024	1,417	380	416	133	152	1,034	388	438	482	241	386	818	842	638	1,259	0	0	0
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	0	0	0	-	8	11	11	12	9	-4	5	-7	-9	-11	-21	-3	-27	-14	-12	-21	2	1	1	3	0	0	0
Net cash provided by operating activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,592	2,990	3,365	1,472	606	123	-37	701	1,260	1,372	740	1,416	0	0	0	-	-	-	-	-	-	-	-	790	0	0	0
Net cash used in operating activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7	-5	33	63	86	103	8	-108	-111	0	0	0	-	-	-	-	-	-	-	-	-7	0	0	0
NET CASH PROVIDED BY OPERATING ACTIVITIES
2,236	2,007	2,344	2,336	2,591	1,880	1,411	2,126	1,058	1,944	1,504	1,478	1,914	1,996	3,178	0	0	0	-	-	-	-	1,464	601	157	26	788	1,364	1,380	632	1,305	1,120	1,258	1,698	1,167	1,357	1,339	1,051	1,108	912	1,097	1,046	783	0	0	0
INVESTING ACTIVITIES
Capital expenditures
293	298	310	318	329	342	336	343	372	402	466	525	547	511	464	384	306	269	231	222	244	257	264	263	239	205	202	178	158	144	133	121	125	151	156	170	181	183	175	175	165	146	145	0	0	0
Cost of acquired companies, net of cash acquired
11	11	63	66	60	767	785	783	836	130	61	61	2	6	2,731	2,758	2,760	5,335	2,633	2,606	2,603	24	9	9	9	9	0	-3	518	525	775	824	303	295	45	0	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of business
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	0	0	0
Proceeds from sales of investment securities available-for-sale
-	-	-	-	-	-	-	-	-	-	74	70	49	26	101	101	88	88	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of investment securities available-for-sale
-	-	-	-	-	-	-	-	-	-	48	49	49	34	42	127	127	127	86	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-2	0	1	-2	-2	-12	-10	-3	-5	-2	-3	-12	-5	8	13	20	9	0	-2	-2	-2	-7	-7	-7	-7	-1	-1	-0	-0	-0	-0	0	0	0	-	-	-	-	-	0	0	0	-	-	-	0
NET CASH USED IN INVESTING ACTIVITIES
-332	-310	-375	-382	-386	-1,096	-1,111	-1,117	-1,163	-483	-498	-554	-564	-553	-3,169	0	0	0	-	-	-	-	-384	-384	87	110	117	140	-700	-710	-947	-992	-464	-460	-212	-178	-190	-192	-184	-178	-181	-162	-148	0	0	0
Net cash used in investing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11	-15	-23	-41	-39	0	0	0	-	-	-	-	-	-	-	-	-1	0	0	0
NET CASH USED IN INVESTING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	128	156	-676	-669	-908	0	0	0	-	-	-	-	-	-	-	-	-147	0	0	0
FINANCING ACTIVITIES
Senior notes and other loan borrowings
114	100	506	550	517	502	1,314	1,243	1,236	1,236	0	0	0	0	1,000	1,000	1,000	2,996	1,996	0	0	0	-	-	-	-	-	-	-	-	499	499	499	499	0	0	0	0	396	0	0	0	-	-	-	0
Senior notes and other loan repayments
100	111	510	600	703	709	681	561	1,084	1,100	750	950	875	850	800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under revolving and securitization credit facilities
187	593	640	1,214	1,239	22,650	25,129	27,075	27,056	11,848	9,336	6,842	7,320	7,156	8,846	8,823	8,315	1,866	111	75	1,484	17,062	17,584	17,584	16,138	2,056	2,330	2,360	2,355	650	60	-618	-440	-101	35	-93	-52	56	2	1,026	1,110	2,104	2,153	0	0	0
Repayments under revolving and securitization credit facilities
316	737	769	1,358	1,254	22,643	25,127	27,050	27,042	11,837	9,335	6,851	6,821	6,654	8,333	8,316	8,310	1,857	111	68	1,469	17,485	17,584	17,584	16,138	1,633	2,330	2,360	2,355	713	60	-601	-442	-107	35	-292	-234	-169	37	1,273	1,346	2,342	2,162	0	0	0
Payment for Debt Extinguishment or Debt Prepayment Cost
-	-	-	-	-	-	22	22	22	22	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of common stock
733	570	674	861	926	855	639	400	160	122	329	1,473	2,059	2,377	2,266	2,081	1,979	1,677	1,859	983	818	1,034	753	653	451	219	484	1,049	1,118	1,318	1,162	954	913	783	840	520	470	511	470	526	525	506	450	0	0	0
Exercises of stock options
115	73	76	65	60	131	138	136	156	122	102	95	98	51	74	89	89	187	193	196	210	135	127	132	149	148	155	156	109	138	115	108	137	124	155	148	157	149	132	136	82	51	22	0	0	0
Cash dividends on common stock
339	336	338	337	335	335	333	331	327	323	320	313	306	297	288	276	267	261	253	244	234	224	214	210	205	200	195	179	163	148	132	130	129	123	117	109	100	95	90	85	77	70	62	0	0	0
Purchases of call options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	211	340	368	350	157	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax withholdings related to restricted share vesting
9	9	5	6	6	6	8	7	7	7	9	12	12	12	22	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-4	-6	-10	-10	-11	-15	-14	-13	-12	-7	-6	-6	-6	-5	-6	7	9	-12	-14	-30	-39	-22	-17	-17	-9	-7	-8	-6	-6	-5	-10	-10	-11	-13	-7	-7	-7	-6	-9	-10	-10	-8	-4	0	0	0
NET CASH USED IN FINANCING ACTIVITIES
-1,087	-1,004	-1,086	-1,343	-1,420	-1,281	-242	68	-207	-214	-1,312	-1,477	-1,471	-629	565	0	0	0	-	-	-	-	-502	-522	-894	-206	-740	-1,593	-1,660	-1,874	-1,116	-472	-379	-268	-787	-488	-436	-437	-275	-336	-371	-375	-504	0	0	0
Net cash used in financing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-50	-94	-90	-28	21	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
NET CASH PROVIDED BY FINANCING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-690	-1,499	-1,570	-1,845	-1,138	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
INCREASE IN CASH AND CASH EQUIVALENTS
816	692	881	610	784	-497	57	1,077	-313	1,246	-306	-553	-120	813	574	-689	188	-1,320	358	1,293	1,640	1,951	577	-305	-650	-69	164	-88	-979	-1,952	-759	-344	414	969	167	689	712	421	648	397	544	508	131	0	0	0